Aspetuck Financial Management LLC Takes Position in UnitedHealth Group Incorporated (NYSE:UNH)

Aspetuck Financial Management LLC acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 1,309 shares of the healthcare conglomerate's stock, valued at approximately $686,000.

Other hedge funds have also recently made changes to their positions in the company. Fort Washington Investment Advisors Inc. OH lifted its stake in shares of UnitedHealth Group by 0.3% during the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate's stock worth $277,641,000 after purchasing an additional 1,465 shares during the last quarter. Sherbrooke Park Advisers LLC purchased a new stake in UnitedHealth Group in the fourth quarter valued at about $515,000. Full Sail Capital LLC increased its holdings in shares of UnitedHealth Group by 2.1% in the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock valued at $815,000 after purchasing an additional 33 shares during the period. Soros Fund Management LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at about $39,413,000. Finally, Silvercrest Asset Management Group LLC increased its holdings in shares of UnitedHealth Group by 47.8% in the fourth quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate's stock valued at $19,625,000 after purchasing an additional 12,550 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Stephen J. Hemsley bought 86,700 shares of the business's stock in a transaction on Friday, May 16th. The stock was bought at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the purchase, the chief executive officer now directly owns 679,493 shares in the company, valued at $196,081,295.01. The trade was a 14.63% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Timothy Patrick Flynn bought 1,533 shares of the business's stock in a transaction on Wednesday, May 14th. The shares were acquired at an average cost of $320.80 per share, with a total value of $491,786.40. Following the purchase, the director now owns 6,033 shares of the company's stock, valued at $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders have purchased 109,408 shares of company stock worth $31,607,768. 0.28% of the stock is owned by corporate insiders.

UnitedHealth Group Price Performance

Shares of NYSE UNH traded up $6.23 during midday trading on Friday, hitting $308.85. The stock had a trading volume of 13,584,804 shares, compared to its average volume of 7,404,577. The company has a market capitalization of $280.17 billion, a PE ratio of 12.93, a P/E/G ratio of 1.46 and a beta of 0.45. The stock has a 50 day simple moving average of $336.21 and a 200-day simple moving average of $453.53. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The company had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. During the same quarter in the previous year, the business posted $6.91 EPS. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a dividend of $2.21 per share. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 2.86%. UnitedHealth Group's dividend payout ratio (DPR) is presently 37.02%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the company. Barclays cut their price objective on UnitedHealth Group to $350.00 and set an "overweight" rating on the stock in a report on Monday, June 2nd. Raymond James Financial lowered UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a report on Wednesday, May 14th. Oppenheimer dropped their target price on UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a report on Wednesday, May 14th. Piper Sandler dropped their target price on UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating on the stock in a report on Tuesday, June 3rd. Finally, Robert W. Baird lowered UnitedHealth Group from an "outperform" rating to a "neutral" rating and set a $312.00 target price on the stock. in a report on Wednesday, June 11th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and an average target price of $415.57.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.